13F HOLDINGS REPORT
Column Group LLC
Quarter ended Q4 2023 · Filed November 13, 2023 · Accession 0000950123-23-010234
Total Value
$150.6M
Positions
7
Other Managers
0
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | RAPT Therapeutics Inc | 75382E109 | 2,680,621 | $44.6M | 29.58% |
| 2 | Revolution Medicines Inc | RVMDW | 1,230,641 | $34.1M | 22.62% |
| 3 | Tenaya Therapeutics, Inc. | TNYA | 9,400,290 | $24.0M | 15.92% |
| 4 | ORIC Pharmaceuticals Inc. | ORIC | 3,568,181 | $21.6M | 14.33% |
| 5 | NGM Biopharmaceuticals Inc | 62921N105 | 18,136,735 | $19.4M | 12.89% |
| 6 | Surrozen, Inc. | SRZNW | 9,414,795 | $4.6M | 3.06% |
| 7 | eFFECTOR Therapeutics Inc | 28202V108 | 4,026,224 | $2.4M | 1.60% |